Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 233

1.

Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk.

Li MS, Liu JL, Wu Y, Wang P, Teng H.

Genet Mol Res. 2011 Nov 29;10(4):2924-33. doi: 10.4238/2011.November.29.3.

PMID:
22179964
[PubMed - indexed for MEDLINE]
Free Article
2.

Polymorphism of vascular endothelial growth factor -1154G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies.

Hong TT, Zhang RX, Wu XH, Hua D.

Mol Biol Rep. 2012 May;39(5):5283-9. doi: 10.1007/s11033-011-1326-9. Epub 2011 Dec 14.

PMID:
22167330
[PubMed - indexed for MEDLINE]
3.

The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis.

Zhang Y, He J, Deng Y, Zhang J, Li X, Xiang Z, Huang H, Tian C, Huang J, Fan H.

BMC Med Genet. 2011 Dec 12;12:159. doi: 10.1186/1471-2350-12-159.

PMID:
22151803
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.

Nam RK, Zhang W, Siminovitch K, Shlien A, Kattan MW, Klotz LH, Trachtenberg J, Lu Y, Zhang J, Yu C, Toi A, Loblaw DA, Venkateswaran V, Stanimirovic A, Sugar L, Malkin D, Seth A, Narod SA.

Cancer Biol Ther. 2011 Dec 1;12(11):997-1004. doi: 10.4161/cbt.12.11.18366. Epub 2011 Dec 1.

PMID:
22130093
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Predicting prostate cancer many years before diagnosis: how and why?

Vickers AJ, Lilja H.

World J Urol. 2012 Apr;30(2):131-5. doi: 10.1007/s00345-011-0795-8. Epub 2011 Nov 20.

PMID:
22101902
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Screening for prostate cancer: early detection or overdetection?

Vickers AJ, Roobol MJ, Lilja H.

Annu Rev Med. 2012;63:161-70. doi: 10.1146/annurev-med-050710-134421. Epub 2011 Nov 3. Review.

PMID:
22053739
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH.

JAMA. 2011 Oct 12;306(14):1549-56. doi: 10.1001/jama.2011.1437.

PMID:
21990298
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, Gleitsmann K, Koenig HC, Lam C, Maltz A, Rugge JB, Lin K.

Ann Intern Med. 2011 Dec 6;155(11):762-71. doi: 10.7326/0003-4819-155-11-201112060-00375. Epub 2011 Oct 7. Review.

PMID:
21984740
[PubMed - indexed for MEDLINE]
9.

Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.

Cai L, Huang W, Chou KC.

Protein Pept Lett. 2012 Jan;19(1):62-9.

PMID:
21919858
[PubMed - indexed for MEDLINE]
10.

The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls.

Zhang H, Xu Y, Zhang Z, Li L.

BMC Cancer. 2011 Sep 13;11:391. doi: 10.1186/1471-2407-11-391.

PMID:
21914193
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

MDM2 SNP309 contributes to tumor susceptibility: a meta-analysis.

Wo X, Han D, Sun H, Liu Y, Meng X, Bai J, Chen F, Yu Y, Jin Y, Fu S.

J Genet Genomics. 2011 Aug 20;38(8):341-50. doi: 10.1016/j.jgg.2011.07.005. Epub 2011 Jul 22.

PMID:
21867960
[PubMed - indexed for MEDLINE]
12.

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact.

Macinnis RJ, Antoniou AC, Eeles RA, Severi G, Al Olama AA, McGuffog L, Kote-Jarai Z, Guy M, O'Brien LT, Hall AL, Wilkinson RA, Sawyer E, Ardern-Jones AT, Dearnaley DP, Horwich A, Khoo VS, Parker CC, Huddart RA, Van As N, McCredie MR, English DR, Giles GG, Hopper JL, Easton DF.

Genet Epidemiol. 2011 Sep;35(6):549-56. doi: 10.1002/gepi.20605. Epub 2011 Jul 18.

PMID:
21769933
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

An empirical analysis of overlap publication in Chinese language and English research manuscripts.

Tucker JD, Chang H, Brandt A, Gao X, Lin M, Luo J, Song P, Sun K, Zhang X.

PLoS One. 2011;6(7):e22149. doi: 10.1371/journal.pone.0022149. Epub 2011 Jul 12.

PMID:
21765946
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.

Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H, Hunter DJ, Kraft P, Thun MJ, Ingles S, Chanock S, Albanes D, Hayes RB, Neal DE, Hamdy FC, Donovan JL, Pharoah P, Schumacher F, Henderson BE, Stanford JL, Ostrander EA, Sorensen KD, Dörk T, Andriole G, Dickinson JL, Cybulski C, Lubinski J, Spurdle A, Clements JA, Chambers S, Aitken J, Gardiner RA, Thibodeau SN, Schaid D, John EM, Maier C, Vogel W, Cooney KA, Park JY, Cannon-Albright L, Brenner H, Habuchi T, Zhang HW, Lu YJ, Kaneva R, Muir K, Benlloch S, Leongamornlert DA, Saunders EJ, Tymrakiewicz M, Mahmud N, Guy M, O'Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English DR, Wahlfors T, Tammela TL, Klarskov P, Nordestgaard BG, Røder MA, Tybjærg-Hansen A, Bojesen SE, Travis R, Canzian F, Kaaks R, Wiklund F, Aly M, Lindstrom S, Diver WR, Gapstur S, Stern MC, Corral R, Virtamo J, Cox A, Haiman CA, Le Marchand L, Fitzgerald L, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Meyer A, Serth J, Yeager M, Berndt SI, Marthick JR, Patterson B, Wokolorczyk D, Batra J, Lose F, McDonnell SK, Joshi AD, Shahabi A, Rinckleb AE, Ray A, Sellers TA, Lin HY, Stephenson RA, Farnham J, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW, Slavov C, Mitev V, Easton DF, Eeles RA; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators, The Australian Prostate Cancer BioResource; PRACTICAL Consortium.

Nat Genet. 2011 Jul 10;43(8):785-91. doi: 10.1038/ng.882.

PMID:
21743467
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Genome-wide association study identifies new prostate cancer susceptibility loci.

Schumacher FR, Berndt SI, Siddiq A, Jacobs KB, Wang Z, Lindstrom S, Stevens VL, Chen C, Mondul AM, Travis RC, Stram DO, Eeles RA, Easton DF, Giles G, Hopper JL, Neal DE, Hamdy FC, Donovan JL, Muir K, Al Olama AA, Kote-Jarai Z, Guy M, Severi G, Grönberg H, Isaacs WB, Karlsson R, Wiklund F, Xu J, Allen NE, Andriole GL, Barricarte A, Boeing H, Bueno-de-Mesquita HB, Crawford ED, Diver WR, Gonzalez CA, Gaziano JM, Giovannucci EL, Johansson M, Le Marchand L, Ma J, Sieri S, Stattin P, Stampfer MJ, Tjonneland A, Vineis P, Virtamo J, Vogel U, Weinstein SJ, Yeager M, Thun MJ, Kolonel LN, Henderson BE, Albanes D, Hayes RB, Feigelson HS, Riboli E, Hunter DJ, Chanock SJ, Haiman CA, Kraft P.

Hum Mol Genet. 2011 Oct 1;20(19):3867-75. doi: 10.1093/hmg/ddr295. Epub 2011 Jul 8.

PMID:
21743057
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

-251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case-control studies.

Wang N, Zhou R, Wang C, Guo X, Chen Z, Yang S, Li Y.

Mol Biol Rep. 2012 Mar;39(3):2831-41. doi: 10.1007/s11033-011-1042-5. Epub 2011 Jun 17.

PMID:
21681427
[PubMed - indexed for MEDLINE]
17.

The CAG repeat polymorphism of androgen receptor gene and prostate cancer: a meta-analysis.

Gu M, Dong X, Zhang X, Niu W.

Mol Biol Rep. 2012 Mar;39(3):2615-24. doi: 10.1007/s11033-011-1014-9. Epub 2011 Jun 12.

PMID:
21667251
[PubMed - indexed for MEDLINE]
18.

CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies.

Wang F, Zou YF, Feng XL, Su H, Huang F.

Prostate. 2011 Aug 1;71(11):1167-77. doi: 10.1002/pros.21332. Epub 2011 Jan 12.

PMID:
21656827
[PubMed - indexed for MEDLINE]
19.

RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis.

Wei B, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, Yan Z, Xuan F, Zhou H, Huang X, Zhang J, Lu P, Shao J.

Mol Biol Rep. 2012 Mar;39(3):2347-53. doi: 10.1007/s11033-011-0985-x. Epub 2011 Jun 9.

PMID:
21656378
[PubMed - indexed for MEDLINE]
20.

XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.

Wei B, Zhou Y, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, Hu Q, Wang Q, Wang Z, Yan Z.

Prostate Cancer Prostatic Dis. 2011 Sep;14(3):225-31. doi: 10.1038/pcan.2011.26. Epub 2011 Jun 7.

PMID:
21647176
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk